Prospective Randomized Clinical Study on Transsphenoidal or Dopamine Drugs Therapy Treat Non-invasive Prolactinoma
Status: Recruiting
Location: See location...
Intervention Type: Procedure, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
the study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:
• non-invasive prolactionma
Locations
Other Locations
China
Sun Yat-sen 5010 program
RECRUITING
Guangzhou
Contact Information
Primary
Zongming Wang, Dr.
wzmyan@foxmail.com
8613570903721
Time Frame
Start Date: 2016-01-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 394
Treatments
Experimental: transsphenoidal surgery treatment
Transsphenoidal surgery treat non-invasive prolactinoma by experienced neurosurgeon
Experimental: dopamine agonist treatment
Minimum effective dose of dopamine agonist, bromocriptine, treat non-invasive prolactinoma
Related Therapeutic Areas
Sponsors
Leads: First Affiliated Hospital, Sun Yat-Sen University